Law360, New York (October 09, 2008, 12:00 AM ET) -- The contact lens patent at the center of a lawsuit between Novartis AG unit CIBA Vision Corp. and Rembrandt Vision Technologies LP, which resulted in a $41 million verdict against CIBA earlier this year, has been found to be invalid for obviousness after a re-examination.
The preliminary results of the re-examination found that the patent held by Rembrandt, which a jury in the U.S. District Court for the Eastern District of Texas found in February that CIBA had infringed, was unpatentable in view of several earlier...
Patent In $41M Contact Lens Suit Invalid: Re-Exam
To view the full article, take a free trial now.
